UNICA IRIS Institutional Research Information System

CADEDDU DESSALVI, CHRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 311.990
NA - Nord America 11.836
AS - Asia 5.928
AF - Africa 1.109
SA - Sud America 907
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 10
Totale 331.837
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 308.748
US - Stati Uniti d'America 11.608
SG - Singapore 2.155
CN - Cina 1.750
ZA - Sudafrica 814
UA - Ucraina 767
BR - Brasile 706
SE - Svezia 690
VN - Vietnam 562
GB - Regno Unito 378
FI - Finlandia 363
IN - India 349
DE - Germania 336
FR - Francia 298
HK - Hong Kong 195
BD - Bangladesh 182
CA - Canada 127
KR - Corea 91
AR - Argentina 69
NL - Olanda 68
KE - Kenya 65
TR - Turchia 63
PK - Pakistan 62
BE - Belgio 56
IQ - Iraq 52
SA - Arabia Saudita 49
JP - Giappone 48
RU - Federazione Russa 48
ID - Indonesia 47
PH - Filippine 47
MX - Messico 46
ES - Italia 44
ZM - Zambia 44
AT - Austria 42
PL - Polonia 39
MY - Malesia 31
NP - Nepal 31
AU - Australia 28
UG - Uganda 27
AE - Emirati Arabi Uniti 26
UZ - Uzbekistan 26
CO - Colombia 25
EC - Ecuador 25
MA - Marocco 24
CL - Cile 23
IR - Iran 19
TN - Tunisia 19
VE - Venezuela 19
EG - Egitto 17
LK - Sri Lanka 15
NG - Nigeria 15
TH - Thailandia 15
GH - Ghana 14
FJ - Figi 12
KH - Cambogia 12
KW - Kuwait 12
PE - Perù 12
PY - Paraguay 12
TW - Taiwan 12
IE - Irlanda 11
JO - Giordania 11
TZ - Tanzania 11
BG - Bulgaria 10
MW - Malawi 10
PT - Portogallo 10
RO - Romania 10
DZ - Algeria 9
ZW - Zimbabwe 9
CU - Cuba 8
JM - Giamaica 8
KZ - Kazakistan 8
LT - Lituania 8
NZ - Nuova Zelanda 8
OM - Oman 8
AL - Albania 7
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
NO - Norvegia 7
BO - Bolivia 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HR - Croazia 6
LC - Santa Lucia 6
QA - Qatar 6
UY - Uruguay 6
CY - Cipro 5
GR - Grecia 5
HN - Honduras 5
LV - Lettonia 5
PG - Papua Nuova Guinea 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
KG - Kirghizistan 4
Totale 331.762
Salva come PNG Salva come JPEG
Città #
Cagliari 212.951
Uta 95.140
Fairfield 1.109
Singapore 1.074
Ashburn 1.035
Woodbridge 947
Dallas 732
Houston 650
Chandler 619
Ann Arbor 564
Boardman 523
San Jose 492
Wilmington 486
Nyköping 452
Seattle 430
Jacksonville 402
Cambridge 391
Beijing 341
Dearborn 246
Helsinki 216
Johannesburg 211
Los Angeles 207
Santa Clara 175
Hong Kong 172
The Dalles 166
Nanjing 161
Ho Chi Minh City 155
Lauterbourg 155
Boston 125
Council Bluffs 121
Hefei 114
Hanoi 108
New York 93
Shanghai 93
Buffalo 90
Dong Ket 90
Seoul 85
Cape Town 78
Pretoria 72
San Diego 68
Guangzhou 64
São Paulo 64
Toronto 60
London 57
Orem 50
Nanchang 49
Redwood City 49
Tianjin 49
Milan 46
Shenyang 46
Chennai 42
Lusaka 42
Munich 42
Chicago 40
Frankfurt am Main 39
Tokyo 38
Hebei 37
Changsha 36
Atlanta 35
Durban 35
Dhaka 33
Brussels 32
Da Nang 32
Nairobi 32
Phoenix 32
Amsterdam 31
Nuremberg 30
Brooklyn 29
Montreal 27
Orange 27
Mumbai 26
Rome 26
Jiaxing 25
Jinan 25
Redondo Beach 25
Warsaw 25
Denver 22
Mountain View 22
Belo Horizonte 21
Lappeenranta 20
Manchester 20
Norwalk 20
Rio de Janeiro 20
Tashkent 20
Zhengzhou 20
Auburn Hills 19
Pune 19
Vienna 19
Baghdad 18
Columbus 18
Sassari 18
Ankara 17
Haiphong 17
Kunming 17
Quito 17
Washington 17
Turku 16
Düsseldorf 15
Kuala Lumpur 15
Paris 15
Totale 323.158
Salva come PNG Salva come JPEG
Nome #
Non-invasive estimation of stroke volume during exercise from oxygen in heart failure patients 75.119
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.912
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.368
Metabolomic approach to profile functional and metabolic changes in heart failure 4.229
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.176
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.930
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.583
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.553
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.532
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.467
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.393
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.343
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.118
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.047
Metabolomics and heart failure: a new and promising scientific approach 2.992
Coronary Artery Disease 2.932
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.835
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.823
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.758
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.754
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.745
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.710
Metabolomics, a promising approach to translational research in cardiology 2.687
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.542
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.489
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.406
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.389
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.319
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.301
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.277
Women-specific predictors of cardiovascular disease risk - new paradigms 2.248
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.241
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.229
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.206
null 2.190
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.185
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.171
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.161
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.155
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.113
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.095
The need of a gender-corrected evidence based medicine 2.075
Gender differences in the development of cardiac complications: A multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up 1.993
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.983
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.968
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.935
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.922
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.912
Current views on anthracycline cardiotoxicity 1.908
A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype 1.905
Arterial hypertension in the female world: Pathophysiology and therapy 1.874
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.871
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.864
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.826
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.788
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.783
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.765
Gender differences in cardiology: is it time for new guidelines? 1.760
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.727
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.710
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.695
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.679
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.668
Role of biomarkers in monitoring antiblastic cardiotoxicity 1.632
Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography 1.590
High prevalence of interatrial septal aneurysm in young adults who were born preterm 1.579
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.579
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.565
Vascular damage-Coronary artery disease 1.551
The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens 1.520
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.515
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.504
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.496
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.482
Antiinflammatory therapy with canakinumab for atherosclerotic disease 1.473
null 1.471
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.463
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography 1.453
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.415
Altered transmural contractility in women affected by cardiac X syndrome 1.401
Metabolomics: a new era in cardiology? 1.350
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.342
Time-to-balloon dependence of coronary flow velocity reserve after primary angioplasty in patients with anterior acute myocardial infarction 1.321
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.310
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.302
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology 1.285
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.283
Consensus: Screening e terapia della cardiopatia ischemica nel paziente diabetico 1.259
null 1.234
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 1.201
Significant QT interval prolongation and long QT in young adult ex-preterm newborns with extremely low birth weight 1.187
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.174
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.141
Mortality for pancreatic cancer among aluminium smelter workers in Sardinia, Italy 1.129
null 1.054
Trastuzumab induced-early cardiac disfunction assessed with TDI: correlation with biological markers of chronic inflammation and oxidative stress. 1.049
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.041
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 983
Gender differences in heart rate variability among patients affected by Parkinson's disease 969
Totale 288.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 396.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 396.390
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.836 0 0 0 0 0 0 0 0 0 2.874 2.835 2.127
2021/202211.512 1.423 722 575 1.132 887 739 551 701 1.216 1.068 1.201 1.297
2022/202316.778 1.663 2.553 2.364 1.487 1.426 1.398 717 1.151 1.126 885 1.277 731
2023/202419.141 981 726 751 1.407 1.973 3.243 3.007 1.263 1.173 1.249 1.714 1.654
2024/2025130.294 9.143 11.685 81.569 18.133 2.082 3.510 2.373 226 443 270 360 500
2025/202610.637 648 513 1.387 975 968 1.049 2.260 922 940 975 0 0
Totale 332.541